Comment on Kyle Bass is slamming the group blocking his new, big short strategy

Kyle Bass is slamming the group blocking his new, big short strategy

Hedge fund manager J. Kyle Bass slammed US Patent & Trademark Office, after it blocked his attempt to challenge a patent held by drugmaker Biogen. The Patent Trial and Appeal Board, which is part of the USPTO, said on Tuesday that it was denying Bass' petition to review a patent for a multiple sclerosis drug licensed by Biogen.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News